In the BioHarmony Drug Report Database
Galantamine
Razadyne, Razadyne Er (galantamine) is a small molecule pharmaceutical. Galantamine was first approved as Razadyne on 2001-02-28. It is used to treat alzheimer disease in the USA. It is known to target acetylcholinesterase.
Trade Name
|
Razadyne, Razadyne Er |
---|---|
Common Name
|
galantamine |
ChEMBL ID
|
CHEMBL659 |
Indication
|
alzheimer disease |
Drug Class
|
Image (chem structure or protein)